University of Alabama

University of Alabama at Birmingham

Contents

Location
Physicians
NABTT Protocol Availability
Contact Information

Location

University of Alabama at Birmingham
1813 Sixth Avenue South
Birmingham, AL 35294

Physician	Burt Nabors, MD
Specialty	Neuro-Oncology
Address	University of Alabama at Birmingham Faculty Office Tower 1020 1530 Third Avenue South Birmingham, AL 35294-3410
Phone Number	205-934-1432
Email	bnabors@uab.edu

NABTT Protocol Availability

Class A: (Newly Diagnosed Glioblastoma Multiforme with Measurable Disease)

Phase I/II Trial of Oxaliplatin as Neoadjuvant Treatment in Adults with Newly Diagnosed Malignant Glioma

Class B: (Newly Diagnosed Glioblastoma Multiforme, Measurable/Non Measurable Disease)

Phase I Study of Combined Radiotherapy and Arsenic Trioxide for the Treatment of Newly Diagnosed Malignant Gliomas
A Safety Run-In/Randomized Phase II Trial of EMD 121974 in Conjunction with Concomitant and Adjuvant Temozolomide with Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme
A Phase II Trial of Talampanel in Conjunction with Radiation Therapy with Concurrent and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme

Class C: (Recurrent High Grade Astrocytoma, with Measurable Disease)

A Phase I Trial of BAY 43-9006 for Patients with Recurrent or Progressive Malignant Glioma
A Phase I/II Trial of BMS-247550 for Treatment of Patients with Recurrent High Grade Gliomas
Phase I Evaluation of the Safety of PS341 in the Treatment of Recurrent Gliomas

Class D: (Locally Recurrent High Grade Astrocytoma)

Class E: (Histology other than High Grade Astrocytoma)

Class F: (Non-therapeutic Protocols)

A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas

For information regarding the protocols available at this center, please contact:

Lorie Black, RN
University of Alabama at Birmingham
Faculty Office Tower 1020
510 20th Street, South
Birmingham, AL 35294-3410
Telephone: 205-934-1842
cbutler@uab.edu